Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 175 of 2228 entries
View as:

Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of BI 113608 in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01681277 Org: User:
Start: 09/30/12 End: 05/31/13 Due: 05/31/14

Safety and Relative Bioavailability of BIBF 1120 Soft Gelatine Capsules Charge 1, BIBF 1120 Soft Gelatine Capsules Charge 2 and BIBF 1120 Drinking Solution in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02182193 Org: User:
Start: 09/30/06 End: - Due: -

GLORIA-AF Registry Program (Phase I)

Phase: N/A Priority: Normal
NCT ID: NCT01428765 Org: User:
Start: 05/31/11 End: 01/31/13 Due: 01/31/14

Effects of a 9-months Treatment of SPIRIVA on Health Related Quality of Life in Patients With COPD

Phase: N/A Priority: Normal
NCT ID: NCT00274053 Org: User:
Start: 04/30/02 End: 04/30/04 Due: 04/30/05

Open Label Study Telmisartan and Amlodipine in Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00614380 Org: User:
Start: 01/31/08 End: - Due: -

A Study to Test How Well Empagliflozin Works in Chinese Patients With Type 2 Diabetes Who Already Take Insulin

Phase: N/A Priority: Normal
NCT ID: NCT04233801 Org: User:
Start: 04/15/20 End: 03/10/22 Due: 03/10/23

Study of Progression to Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Incidence/Management and Treatment

Phase: N/A Priority: Normal
NCT ID: NCT05875532 Org: User:
Start: 04/20/23 End: 05/01/23 Due: 05/01/24

A Study to Compare Tissue and Liquid Biopsies in People With Different Types of Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05708599 Org: User:
Start: 03/01/23 End: 12/07/27 Due: 12/07/28

Bioequivalence of a New Asasantin Formulation Extended Release (ER) Compared to the Commercially Available Asasantin Formulation (Aggrenox®; Extended Release) in Healthy Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02273531 Org: User:
Start: 01/31/04 End: - Due: -

Pharmacokinetics of Tipranavir Soft Elastic Capsules (SEDDS) and Ritonavir and Their Effects on Cytochrome P-450 (3A4) in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02251132 Org: User:
Start: 10/31/00 End: - Due: -

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of BI 1181181 in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02106247 Org: User:
Start: 04/30/14 End: 06/30/14 Due: 06/30/15

Safety and Tolerability of BI 638683 After Single Rising Oral Doses in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01195688 Org: User:
Start: 09/30/10 End: - Due: -

Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01719003 Org: User:
Start: 10/31/12 End: 12/31/14 Due: 12/31/15

Telmisartan Versus Amlodipine in Patients With Mild-to-Moderate Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT02177409 Org: User:
Start: 04/30/98 End: - Due: -

Bioavailability and Pharmacokinetics of BI 135585 XX Administered as Tablet With and Without Food

Phase: N/A Priority: Normal
NCT ID: NCT01286571 Org: User:
Start: 01/31/11 End: - Due: -

Safety Study of Tipranavir Co-administered With Low-dose Ritonavir (TPV/r) in Patients With Advanced HIV-1 Infection and Limited Treatment Options

Phase: N/A Priority: Normal
NCT ID: NCT00144287 Org: User:
Start: 05/31/04 End: 04/30/06 Due: 04/30/07

Tipranavir/Ritonavir Low Dose Pharmacokinetics in Treatment Naive Patients

Phase: N/A Priority: Normal
NCT ID: NCT00530920 Org: User:
Start: 10/31/07 End: - Due: -

A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose Weight

Phase: N/A Priority: Normal
NCT ID: NCT04667377 Org: User:
Start: 03/08/21 End: 10/07/22 Due: 10/07/23

BIBF 1120 Versus Bevacizumab in Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00904839 Org: User:
Start: 05/31/09 End: 01/31/12 Due: 01/31/13

An Evaluation of Three Doses of NS 2330 in Patients With Mild to Moderate Dementia of the Alzheimer's Type

Phase: N/A Priority: Normal
NCT ID: NCT00153010 Org: User:
Start: 02/28/03 End: - Due: -

A Study to Test How Effective and Safe Different Doses of BI 655130 Are in Patients With a Moderate to Severe Form of the Skin Disease Palmoplantar Pustulosis

Phase: N/A Priority: Normal
NCT ID: NCT04015518 Org: User:
Start: 07/31/19 End: 07/28/21 Due: 07/28/22

JARDIANCE® Post Marketing Surveillance in Korean Patients With Chronic Kidney Disease (CKD)

Phase: N/A Priority: Normal
NCT ID: NCT06287073 Org: User:
Start: 03/29/24 End: 04/30/25 Due: 04/30/26

Efficacy of Antistax® in Improving Microcirculation of the Skin in the Leg in Patients Suffering From Chronic Venous Insufficiency

Phase: N/A Priority: Normal
NCT ID: NCT02191163 Org: User:
Start: 04/30/02 End: - Due: -

Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT02230982 Org: User:
Start: - End: - Due: -

The Safety and Effectiveness of Nevirapine and Zidovudine, Given Separately and Together, in HIV-1 Infected Patients Who Have No Symptoms of the Disease

Phase: N/A Priority: Normal
NCT ID: NCT00002324 Org: User:
Start: - End: - Due: -